Latest filing published 29 Aug 2022 for Vaxxinity, Inc., €4,982.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Farshad Guirakhoo: trading record in brief
Farshad Guirakhoo (senior executive) discloses dealings in Vaxxinity, Inc. to SEC (Form 4). Between 13 January 2022 and 22 August 2022, the trades on record add up to 5 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 29 August 2022: an option exercise of €1, in Vaxxinity, Inc. Filings reach the SEC (Form 4) feed a median of 14 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Farshad Guirakhoo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.5747.9% of flowClass A common stockSEC:0001437749-22-021457:0
- 10,000 shares@ US$0.5752.1% of flowClass A common stockSEC:0000899243-22-016779:0
2 of 2 declarations